Statins for primary prevention of venous thromboembolism

Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case–control study

“…These findings likely reflect the potent effect of these agents on the coagulation cascade, as has been well documented in large-scale studies encompassing a number of clinical settings [23][24][25]. Of note, few studies have found that antiplatelet agents reduce the risk of thrombosis in patients with PICCs [25].…”

Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case–control study

“…These findings likely reflect the potent effect of these agents on the coagulation cascade, as has been well documented in large-scale studies encompassing a number of clinical settings [23][24][25]. Of note, few studies have found that antiplatelet agents reduce the risk of thrombosis in patients with PICCs [25].…”

Risk of Venous Thromboembolism in Statin Users Compared to Fibrate Users in the United Kingdom Clinical Practice Research Datalink (UK CPRD) GOLD

“……”

Postoperative statin therapy is not associated with reduced incidence of venous thromboembolic events following kidney transplantation

“…In patients with cancer, those treated with statins were less likely to develop VTE compared to patients not taking statins 13,53 . However, meta‐analyses and systematic reviews have presented inconclusive results regarding any consistent effect of statin therapy on the incidence of VTE 14,54–56 . For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20% could not be ruled out.…”

“…For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20% could not be ruled out. The results of a Cochrane group analysis suggested that rosuvastatin therapy may be associated with a reduction in the incidence of VTE, but the lack of randomized clinical trials was a limitation 55 . In addition, although there is data to suggest that venous and arterial thromboembolic events may share similar risk factor profiles and that either event may be a marker for increased risk for the other, 54,57–59 it is unclear that hyperlipidemia is an independent risk factor for VTE.…”

“…Overall survival by statin use dence of VTE. 14,[54][55][56] For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20%…”

Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case–control study

“…These findings likely reflect the potent effect of these agents on the coagulation cascade, as has been well documented in large-scale studies encompassing a number of clinical settings [23][24][25]. Of note, few studies have found that antiplatelet agents reduce the risk of thrombosis in patients with PICCs [25].…”

Risk of Venous Thromboembolism in Statin Users Compared to Fibrate Users in the United Kingdom Clinical Practice Research Datalink (UK CPRD) GOLD

“……”

Postoperative statin therapy is not associated with reduced incidence of venous thromboembolic events following kidney transplantation

“…In patients with cancer, those treated with statins were less likely to develop VTE compared to patients not taking statins 13,53 . However, meta‐analyses and systematic reviews have presented inconclusive results regarding any consistent effect of statin therapy on the incidence of VTE 14,54–56 . For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20% could not be ruled out.…”

“…For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20% could not be ruled out. The results of a Cochrane group analysis suggested that rosuvastatin therapy may be associated with a reduction in the incidence of VTE, but the lack of randomized clinical trials was a limitation 55 . In addition, although there is data to suggest that venous and arterial thromboembolic events may share similar risk factor profiles and that either event may be a marker for increased risk for the other, 54,57–59 it is unclear that hyperlipidemia is an independent risk factor for VTE.…”

“…Overall survival by statin use dence of VTE. 14,[54][55][56] For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20%…”

Patterns, risk factors and treatment associated with PICC-DVT in hospitalized adults: A nested case–control study

“…These findings likely reflect the potent effect of these agents on the coagulation cascade, as has been well documented in large-scale studies encompassing a number of clinical settings [23][24][25]. Of note, few studies have found that antiplatelet agents reduce the risk of thrombosis in patients with PICCs [25].…”

Risk of Venous Thromboembolism in Statin Users Compared to Fibrate Users in the United Kingdom Clinical Practice Research Datalink (UK CPRD) GOLD

“……”

Postoperative statin therapy is not associated with reduced incidence of venous thromboembolic events following kidney transplantation

“…In patients with cancer, those treated with statins were less likely to develop VTE compared to patients not taking statins 13,53 . However, meta‐analyses and systematic reviews have presented inconclusive results regarding any consistent effect of statin therapy on the incidence of VTE 14,54–56 . For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20% could not be ruled out.…”

“…For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20% could not be ruled out. The results of a Cochrane group analysis suggested that rosuvastatin therapy may be associated with a reduction in the incidence of VTE, but the lack of randomized clinical trials was a limitation 55 . In addition, although there is data to suggest that venous and arterial thromboembolic events may share similar risk factor profiles and that either event may be a marker for increased risk for the other, 54,57–59 it is unclear that hyperlipidemia is an independent risk factor for VTE.…”

“…Overall survival by statin use dence of VTE. 14,[54][55][56] For example, Rahimi et al found that although not statistically significant, a reduction in the rate of VTE of up to 20%…”